论文部分内容阅读
目的:分析和探究急性心肌梗死后心绞痛的临床治疗方法和效果。方法:随机选择了2015年4月-2016年4月我院收治的120例急性心肌梗死后心绞痛患者作为研究对象,将其分为对照组和实验组,对照组患者给予常规治疗,而实验组患者在对照组的基础上又口服了麝香保心丸,然后对两组患者的治疗效果进行记录和对比。结果:实验组患者的治疗总有效率为98.33%,比对照组的90.0%高,而且实验组患者的心电图检测改善率(96.67%)高于对照组(85.0%),他们之间的数据差异具有统计学意义(P<0.05)。结论:在对急性心肌梗死后心绞痛患者进行临床治疗时,最好根据患者的临床症状为其提供针对性的药物治疗,从而确保患者的治疗效果和生活质量。
Objective: To analyze and explore the clinical treatment of angina pectoris after acute myocardial infarction and its effect. Methods: A total of 120 patients with acute myocardial infarction and angina pectoris who were admitted to our hospital from April 2015 to April 2016 were randomly selected as the control group and experimental group. The control group was given routine treatment, while the experimental group Patients in the control group on the basis of oral administration of musk pill, and then the treatment of two groups of patients were recorded and compared. Results: The total effective rate of the experimental group was 98.33%, higher than 90.0% of the control group, and the improvement rate of electrocardiogram (96.67%) in the experimental group was higher than that of the control group (85.0%). The difference of the data between them Statistically significant (P <0.05). Conclusions: When clinical treatment of patients with angina after acute myocardial infarction, it is best to provide targeted drug treatment based on the clinical symptoms of patients to ensure the treatment effect and quality of life of patients.